Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1301065

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1301065

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Size, Share & Trends Analysis Report By Services (Manufacturing, Research), By Country (Chile, Brazil), And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Growth & Trends

The Latin America pharmaceutical contract manufacturing & research services market size is expected to reach USD 40.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2023 to 2030. The low manufacturing costs and growing demand for generics are the key factors driving the market growth. Moreover, factors, such as the growing pharmaceutical industry, rising investments in R&D, and technological advancements, are responsible for market growth. The shift from cost control to value-added solutions, the introduction of novel technologically equipped facilities, and risk-sharing between pharma and CMOs are also contributing to the industry growth.

Companies have started financing efforts to meet the rising demand for biological drugs, which, in turn, leads to an increase in the development of pharmaceutical products. This steady commercial success of biopharmaceuticals is expected to accelerate the growth of the regional market for pharmaceutical contract manufacturing & research services over the forecast period. Pharmaceutical contract manufacturing and research activities in Brazil are subject to severe requirements to maintain Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) compliance. These laws cover a wide range of topics, such as facility requirements, quality control systems, documentation practices, and employee qualifications.

Contract manufacturing and research companies must receive the relevant authorizations and certificates from ANVISA, which includes a thorough review of their facilities, processes, and quality management systems. Technological advances in areas, such as biopharmaceutics, personalized medicine, and analytical methods, have increased the complexity of drug production and research processes. Outsourcing these functions to specialist contract service providers in Latin America can provide access to state-of-the-art facilities and expertise.

Latin America Pharmaceutical Contract Manufacturing & Research Services Market Report Highlights

  • Manufacturing services dominated the market with the largest share of 66.2% in 2022. Based on services, the market is segmented into manufacturing and research. Contract manufacturing services comprise the solutions and facilities for the production of API/bulk drugs, advanced drug delivery formulations, packaging, and finished dose formulations
  • Brazil accounted for the largest revenue share of 69.4% in 2022. The low manufacturing costs of pharmaceuticals and the presence of a significant number of GMP-certified plants are attracting investors from other countries to establish their presence in Brazil
  • Mexico is anticipated to register a considerable CAGR of 7.5% during the forecast period. This is due to the Indian pharmaceutical industry investing in the country
  • Key players have undertaken various growth strategies, such as business expansion, mergers, and acquisitions, to gain higher market shares. For instance, in September 2020, Charles River Laboratories Inc. announced that it has opened a microbial identification lab in Brazil
Product Code: GVR-1-68038-745-2

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Country scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1:
    • 1.9.2. Objective 2:
    • 1.9.3. Objective 3:
    • 1.9.4. Objective 4:

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Industry challenges
  • 3.2. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
    • 3.2.2. PESTEL Analysis
    • 3.2.3. Major Deals & Strategic Alliances Analysis
    • 3.2.4. Market Entry Strategies
    • 3.2.5. COVID-19 Analysis

Chapter 4. Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Service Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Manufacturing
    • 4.1.2. Research
  • 4.2. Latin America Pharmaceutical Contract Manufacturing & Research Services Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Service Market Size & Forecasts and Trend Analysis, 2018 to 2030
    • 4.4.1 Manufacturing Latin America Pharmaceutical Contract Manufacturing and Research Services Market 2018 to 2030 (USD Billion)
    • 4.4.2 Research Latin America Pharmaceutical Contract Manufacturing and Research Services Market 2018 to 2030 (USD Billion)

Chapter 5. Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Country Estimates & Trend Analysis

  • 5.1. Country Market Share Analysis, 2022 & 2030
  • 5.2. Country Market Dashboard
  • 5.3. Country Market Snapshot
  • 5.4. Latin America
    • 5.4.1. Latin America Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Billion)
    • 5.4.2. Brazil
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030
    • 5.4.3. Mexico
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Mexico Market Estimates and Forecasts, 2018 - 2030
    • 5.4.4. Argentina
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Argentina Market Estimates and Forecasts, 2018 - 2030
    • 5.4.5. Colombia
      • 4.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Colombia Market Estimates and Forecasts, 2018 - 2030
    • 5.4.6. Chile
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Chile Market Estimates and Forecasts, 2018 - 2030
    • 5.4.7. Venezuela
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Venezuela Market Estimates and Forecasts, 2018 - 2030
    • 5.4.8. Peru
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Peru Market Estimates and Forecasts, 2018 - 2030
    • 5.4.9. Uruguay
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Uruguay Market Estimates and Forecasts, 2018 - 2030
    • 5.4.10. Ecuador
      • 5.4.10.1. Key Country Dynamics
      • 5.4.10.2. Competitive Scenario
      • 5.4.10.3. Regulatory Framework
      • 5.4.10.4. Ecuador Market Estimates and Forecasts, 2018 - 2030
    • 5.4.11. Bolivia
      • 5.4.11.1. Key Country Dynamics
      • 5.4.11.2. Competitive Scenario
      • 5.4.11.3. Regulatory Framework
      • 5.4.11.4. Bolivia Market Estimates and Forecasts, 2018 - 2030

Chapter 6. Competitive Landscape

  • 6.1. Lonza
    • 6.1.1. Company overview
    • 6.1.2. Financial performance
    • 6.1.3. Service benchmarking
    • 6.1.4. Strategic initiatives
  • 6.2. Boehringer Ingelheim International GmbH
    • 6.2.1. Company overview
    • 6.2.2. Financial performance
    • 6.2.3. Service benchmarking
    • 6.2.4. Strategic initiatives
  • 6.3. Pfizer Inc.
    • 6.3.1. Company overview
    • 6.3.2. Financial performance
    • 6.3.3. Service benchmarking
    • 6.3.4. Strategic initiatives
  • 6.4. Charles River Laboratories
    • 6.4.1. Company overview
    • 6.4.2. Financial performance
    • 6.4.3. Service benchmarking
    • 6.4.4. Strategic initiatives
  • 6.5. Laboratory of America Holdings
    • 6.5.1. Company overview
    • 6.5.2. Financial performance
    • 6.5.3. Service benchmarking
    • 6.5.4. Strategic initiatives
  • 6.6. Recipharm AB
    • 6.6.1. Company overview
    • 6.6.2. Financial performance
    • 6.6.3. Service benchmarking
    • 6.6.4. Strategic initiatives
  • 6.7. IQVIA, Inc.
    • 6.7.1. Company overview
    • 6.7.2. Financial performance
    • 6.7.3. Service benchmarking
    • 6.7.4. Strategic initiatives
  • 6.8. AbbVie, Inc.
    • 6.8.1. Company overview
    • 6.8.2. Financial performance
    • 6.8.3. Service benchmarking
    • 6.8.4. Strategic initiatives
  • 6.9. Catalent, Inc.
    • 6.9.1. Company overview
    • 6.9.2. Financial performance
    • 6.9.3. Service benchmarking
    • 6.9.4. Strategic initiatives
  • 6.10. West Pharmaceutical Services, Inc.
    • 6.10.1. Company overview
    • 6.10.2. Financial performance
    • 6.10.3. Service benchmarking
    • 6.10.4. Strategic initiatives
Product Code: GVR-1-68038-745-2

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Region 2018 - 2030 (USD Billion)
  • Table 4 Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 5 Brazil Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 6 Mexico Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 7 Argentina Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 8 Colombia Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 9 Chile Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 10 Venezuela Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 11 Peru Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 12 Uruguay Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 13 Ecuador Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)
  • Table 14 Bolivia Latin America Pharmaceutical Contract Manufacturing & Research Services Market, by Service, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modelling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Primary research pattern
  • Fig. 8 Primary interviews in Latin America
  • Fig. 9 Market Snapshot
  • Fig. 10 Segment Snapshot
  • Fig. 11 Segment Snapshot
  • Fig. 12 Competitive Landscape Snapshot
  • Fig. 13 Latin America Pharmaceutical Contract Manufacutring and Research Services market segmentation
  • Fig. 14 Parent market outlook (2022)
  • Fig. 15 Related/ancillary market outlook (2022)
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Market restraint relevance analysis (Current & future impact)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 SWOT analysis, by a factor (political & legal, economic and technological)
  • Fig. 20 Latin America Pharmaceutical Contract Manufacturing & Research Services market segment dashboard
  • Fig. 21 Latin America Pharmaceutical Contract Manufacturing & Research Services market: Service movement Analysis
  • Fig. 22 Manufacturing Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Research Latin America Pharmaceutical Contract Manufacturing & Research Services market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Latin America Pharmaceutical Contract Manufacturing & Research Services Market: Country movement analysis
  • Fig. 25 Brazil market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Mexico market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Argentina market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Colombia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Chile market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Venezuela market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Peru market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 32 Uruguay market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Ecuador market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Bolivia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Rest of Latin America market estimates and forecast, 2018 - 2030 (USD Billion)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!